
Dr. Jennifer Wargo
Cancer Treatment
20+
Years of Experience
About Dr. Jennifer Wargo
Dr. Jennifer A. Wargo, MD, MMSc is an Endowed Professor of Surgical Oncology and Genomic Medicine at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Wargo is a world renowned physician-scientist and a leader in the development of treatment strategies that target the interaction between the gut microbiome and the host response to cancer therapies such as immunotherapy, melanoma, and targeted therapy.
-
Professional Background
-
Years of practice: 20+ years
-
Hospital affiliation: The University of Texas MD Anderson Cancer Center in Houston, Texas
-
Title and roles: Endowed Professor, Surgical Oncology & Genomic Medicine; Core Member, James P. Allison Institute; Program Director, PRIME-TR (Program for Innovative Microbiome and Translational Research)
-
Medical specialties: Surgical oncology, melanoma, cancer immunotherapy, microbiome research, targeted therapy
-
Degrees: MD; MMSc (Master of Medical Sciences)
-
Residency: Completed Surgical residency training at Massachusetts General Hospital; performed two fellowships focused on surgical oncology with sub-specialty on Cancer Immunotherapy.
-
Joined MD Anderson: September 2013
-
-
Innovations and contributions
-
Dr. Wargo was elected as a member to the National Academy of Medicine for her significant work in melanoma response and resistance to cancer therapies and for identifying the interactions between the microbiome and response to cancer therapy, including ground-breaking discoveries in how the microbiome affects response to immunotherapy.
-
Her study published in Science* showed that a high-fiber diet was linked to greater responses to immunotherapy treatments in melanoma patients and led to a clinical trial that is currently open at MD Anderson.
-
In 2020 she founded the Program for Innovative Microbiome and Translational Research (PRIME-TR) at MD Anderson to encourage translational microbiome research in order to improve cancer outcomes.
-
She plays a key role in MD Anderson's Melanoma Moonshot program and analyzes samples taken during the administration of a clinical trial using targeted therapies and immunotherapies for melanoma patients.
-
Dr. Wargo represents the new generation of oncologist-scientist, a specialist who combines the laboratory and clinical settings, bringing her patients to MD Anderson novel immunotherapies and innovative microbiome therapies for cancer.
Good to know
Speciality
Performed by Dr. Jennifer Wargo
CureMeAbroadIs Absolutely Free
Just discovery so you can choose what's right for you!


World's No. 1 Medical Discovery Platform
Dr. Jennifer Wargo
Jennifer Wargo has been practicing medicine since 2006, giving them over 19 years of clinical experience. They currently serve as Professor of Genomic Medicine and Surgical Oncology and have built a focused career in surgical oncologist and cancer researcher.
Dr. Jennifer Wargo
You can request a consultation with Jennifer Wargo through CureMeAbroad by submitting your details. Video consultations are available for international patients before travel through CureMeAbroad.
Dr. Jennifer Wargo
Cancer treatment costs with Jennifer Wargo vary by cancer type, stage, and treatment protocol. Patients frequently save 40-70% compared to equivalent care in the US or UK. CureMeAbroad can help obtain a cost estimate after your medical records and pathology reports are reviewed.
How many years of experience does Jennifer Wargo have?

Dr. Jennifer Wargo
Jennifer Wargo has been practicing medicine since 2006, giving them over 19 years of clinical experience. They currently serve as Professor of Genomic Medicine and Surgical Oncology and have built a focused career in surgical oncologist and cancer researcher.
Which You Wanted To See
Topic Related


